Pulmonary Embolism Support Group
By far the most common form of pulmonary embolism is a thromboembolism, which occurs when a blood clot, generally a venous thrombus, becomes dislodged from its site of formation and embolizes to the arterial blood supply of one of the lungs. Symptoms may include difficulty breathing, pain during breathing, and more rarely circulatory instability and death.
"A follow-up subanalysis of the most influential atrial-fibrillation (AF) trial of dabigatran etexilate (Pradaxa, Boehringer Ingelheim), an oral antithrombin alternative to warfarin, identified a common gene variant that seems to influence the bleeding risk associated with the drug but not its antithrombotic efficacy [1]."
http://tinyurl.com/9cweaeu
But I found it interesting. (I'm a pack rat)
"According to the FDA release, Sun is voluntarily recalling one lot of Nimodipine Capsules, 30 mg, which are used to decrease problems due to bleeding in the brain. The recall came after a customer complained that there were crystals of nimodipine in the solution.
There have been no reports of adverse events, and the FDA says the clinical health implications of the crystals is unknown. But the agency warned that the crystals might mean the product is no longer "bioequivalent and may potentially affect patients who are being treated for a medical emergency."
http://www.fiercepharmamanufacturing.com/story/sun-recalls-biosimilar-used-treating-brain-bleeding/2012-09-06
Read more: Sun recalls biosimilar used for treating brain bleeding - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/sun-recalls-biosimilar-used-treating-brain-bleeding/2012-09-06#ixzz25iE2wNNN
Subscribe: http://www.fiercepharmamanufacturing.com/signup?sourceform=Viral-Tynt-FiercePharma Manufacturing-FiercePharma Manufacturing